当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析 - 利润表

冠昊生物

(300238)

  

流通市值:65.86亿  总市值:67.83亿
流通股本:2.57亿   总股本:2.65亿

利润表

按照会计年度查询:
报告期2020-06-302020-03-312019-12-312019-06-30
一、营业总收入203,611,983.9493,348,010.41437,886,453.72207,678,163.19
营业收入203,611,983.9493,348,010.41437,886,453.72207,678,163.19
二、营业总成本172,678,073.6583,185,081.78519,589,041.46213,990,429.92
营业成本56,526,647.8125,982,340.38141,442,010.9867,870,251.74
营业税金及附加678,994.55302,552.893,737,676.18970,732.52
销售费用68,145,077.2834,821,928.41185,577,265.3586,467,339.46
管理费用22,634,051.7110,448,665.03103,581,534.4833,146,711.88
财务费用7,597,152.724,348,113.9115,299,230.797,241,937.64
资产减值损失-839,223.28-240,050.69-410,856,232.81-2,251,854.12
三、其他经营收益1,795,939.711,282,058.25-806,336.01-5,336,821.52
允许价值变动净收益--------
投资净收益-353,328.82-115,523.92-13,982,5768,471,527.88
联营、合营企业投资收益-353,328.82---7,775,600.22-515,265.11
汇兑净收益--------
四、营业利润33,752,558.9714,353,275.79-486,857,495.946,276,372.56
营业外收入331,650.3712,286.22,058,576.68428,219.44
营业外支出86,407.0970,429.9578,908.65168,946.22
非流动资产处置净损失--------
五、利润总额33,997,802.2514,295,132.04-484,877,827.916,535,645.78
所得税7,228,202.673,875,657.355,874,439.464,158,965.91
未确认的投资损失--------
六、净利润(百万元)36.8626.9711.55-465.33
少数股东损益-197,257.75-1,130,200.27-25,422,450.74-6,219,020.92
归属于母公司股东的净利润26,966,857.3311,549,674.96-465,329,816.638,595,700.79
七、每股收益0.10.04-1.75--
基本每股收益0.10.04-1.750.03
稀释每股收益0.10.04-1.750.03
TOP↑